Literature DB >> 22903433

Taurine and central nervous system disorders.

Janet Menzie1, Chunliu Pan, Howard Prentice, Jang-Yen Wu.   

Abstract

In the present era, investigators seek to find therapeutic interventions that are multifaceted in their mode of action. Such targets provide the most advantageous routes for addressing the multiplicity of pathophysiological avenues that lead to neuronal dysfunction and death observed in neurological disorders and neurodegenerative diseases. Taurine, an endogenous amino acid, exhibits a plethora of physiological functions in the central nervous system. In this review, we describe the mode of action of taurine and its clinical application in the neurological diseases: Alzheimer's disease, Parkinson's disease and Huntington's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903433     DOI: 10.1007/s00726-012-1382-z

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  37 in total

1.  Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson's disease.

Authors:  Jian Ding; Jiejin Zhang; Xixi Wang; Li Zhang; Siming Jiang; Yongsheng Yuan; Junyi Li; Lin Zhu; Kezhong Zhang
Journal:  J Neural Transm (Vienna)       Date:  2016-11-22       Impact factor: 3.575

2.  Taurine protects noradrenergic locus coeruleus neurons in a mouse Parkinson's disease model by inhibiting microglial M1 polarization.

Authors:  Liyan Hou; Yuning Che; Fuqiang Sun; Qingshan Wang
Journal:  Amino Acids       Date:  2018-03-05       Impact factor: 3.520

Review 3.  Taurine and the Brain.

Authors:  Simon S Oja; Pirjo Saransaari
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Influences of Taurine Pharmacodynamics and Sex on Active Avoidance Learning and Memory.

Authors:  Wei Zhu; George B Cruz; Zaid Ayaz; Jewel N Joseph; Akil Boby; Patrick Cadet; Lorenz S Neuwirth
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Therapeutic effect of taurine against aluminum-induced impairment on learning, memory and brain neurotransmitters in rats.

Authors:  Lu Wenting; Liu Ping; Jiao Haitao; Qiao Meng; Ren Xiaofei
Journal:  Neurol Sci       Date:  2014-04-27       Impact factor: 3.307

6.  In vivo proton magnetic resonance spectroscopy detection of metabolite abnormalities in aged Tat-transgenic mouse brain.

Authors:  Jason J Paris; Xi Chen; Joseph Anderson; Alaa N Qrareya; Fakhri Mahdi; Fei Du; Jay P McLaughlin; Marc J Kaufman
Journal:  Geroscience       Date:  2021-04-05       Impact factor: 7.713

7.  Taurine mitigates bile duct obstruction-associated cholemic nephropathy: effect on oxidative stress and mitochondrial parameters.

Authors:  Narges Abdoli; Issa Sadeghian; Negar Azarpira; Mohammad Mehdi Ommati; Reza Heidari
Journal:  Clin Exp Hepatol       Date:  2021-03-25

8.  Characteristics of mental health implications and plasma metabolomics in patients recently recovered from COVID-19.

Authors:  Lian Yang; Mei Zhou; Lingli Li; Ping Luo; Wenliang Fan; Juanjuan Xu; Qing Chen; Feng Pan; Ping Lei; Chuansheng Zheng; Yang Jin
Journal:  Transl Psychiatry       Date:  2021-05-21       Impact factor: 6.222

9.  Taurine ameliorates thioacetamide induced liver fibrosis in rats via modulation of toll like receptor 4/nuclear factor kappa B signaling pathway.

Authors:  Nancy S Younis; Amal M H Ghanim; Mohammad A Elmorsy; Heba A Metwaly
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

10.  Protective role of taurine against oxidative stress (Review).

Authors:  Stella Baliou; Maria Adamaki; Petros Ioannou; Aglaia Pappa; Mihalis I Panayiotidis; Demetrios A Spandidos; Ioannis Christodoulou; Anthony M Kyriakopoulos; Vassilis Zoumpourlis
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.